SOLI - Solithromycin Pediatric Development Program (Phase 2/3 start up)- MOD 2
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
April 13, 2016
End Date
June 30, 2017
Administered By
Duke Clinical Research Institute
Awarded By
Cempra Pharmaceuticals, Inc.
Start Date
April 13, 2016
End Date
June 30, 2017